Neogenis Falls Short Of ‘Competent And Reliable’ Standard For Supplement Claims
This article was originally published in The Tan Sheet
Executive Summary
The National Advertising Review Board says Neogenis Labs does not support its Neo40 supplement claims including circulation and blood pressure with “competent and reliable” evidence. “At best” the firm’s evidence “may provide a reasonable basis for narrower claims,” the appellate panel said in a review of an October 2014 NAD decision.